Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia

The Journal of Clinical Investigation
A CorsiniA L Catapano

Abstract

We studied a 32-yr-old man with a benign paraproteinemia (IgA) affected by severe nonfamilial hypercholesterolemia. In vitro experiments demonstrated that lipoprotein-deficient serum (LPDS) from the patient inhibited the binding of low density lipoprotein (LDL) to human skin fibroblasts cultured in vitro (up to 70%) whereas LPDS from controls had no effect. Removal of IgA from the patient's serum by immunoprecipitation with mono-specific antisera abolished the inhibition of LDL binding. IgA isolated from the serum of the patient by affinity chromatography inhibited, in a dose-dependent manner, the binding of LDL to human skin fibroblasts in vitro, thus showing an IgA-mediated effect. Ligand-blotting experiments demonstrated that the paraprotein directly interacts with the LDL receptor, thus inhibiting the binding of the lipoprotein. Treatment of the receptor protein with reducing agents blocked the interaction of the antibody with the LDL receptor. From these data we speculate that this autoantibody may be responsible for the severe nonfamilial hypercholesterolemia of the patient.

References

Apr 1, 1977·Atherosclerosis·J L Beaumont, V Beaumont
Apr 15, 1975·Klinische Wochenschrift·W Riesen, G Noseda
Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
Feb 1, 1975·Bruxelles médical·J P Gassée, H M Brems
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R W MilneY L Marcel
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R ThompsonN B Myant
Dec 2, 1982·The New England Journal of Medicine·S I TaylorP Gorden
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

May 17, 1990·Klinische Wochenschrift·G FeussnerR Ziegler
Nov 19, 2009·Annals of Hematology·Benjamin MisselwitzJörg D Seebach
Jul 27, 2001·Current Rheumatology Reports·J T Merrill
Sep 12, 2003·Current Rheumatology Reports·Joan T Merrill
Sep 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M Harada-ShibaA Yamamoto
Dec 20, 2012·Circulation. Cardiovascular Genetics·Sergio Fazio, MacRae F Linton
Aug 1, 1991·European Journal of Clinical Investigation·A CorsiniA L Catapano
May 11, 1989·The New England Journal of Medicine·S KiharaS Tarui
May 15, 2020·Acta Haematologica·Sophie C RagbourneMartin A Crook

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.